Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by priceless2on Oct 21, 2017 12:39pm
110 Views
Post# 26840688

RE:RE:RE:RE:RE:Market Passion in the affirmative...NOT!

RE:RE:RE:RE:RE:Market Passion in the affirmative...NOT!LED

I am wondering how much due diligence HL did prior to there huge PP
buy in, and going into debt to do it,  have they been doing there own testing of the
molecule for the past few years, .....  how about this conspiracy theory of corporate 
espionage, janitor in the labs , secretaries anyone in the lab, anyone can be bought to provide 
good information if paid, we all have the greed factor , crazier things have happened, that being 
said , I am happy an excited to move forward with PP, they did protect their 
investment but if they had their doubts HL would have never ponied up,!!!

lets hope that we get some positive news soon that will drive up the Sp
or a large regional deal or CVR , 

Bullboard Posts